Guideline document

Your browser can't display PDFs inline. Open the guideline in a new tab.

This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.

45 Views
0 Likes
0 Shares
0 Comments

StayCurrentMD

View profile →

Clinical Guideline

Congenital Pulmonary Airway Malformation: APSA Prenatal Counseling Series

Topic overview

Educational resource from APSA's Fetal Diagnosis and Treatment Committee providing prenatal counseling guidance for congenital pulmonary airway malformation (CPAM). Designed to help clinicians discuss diagnosis, prognosis, and management options with expectant families.

Key Takeaways

  • CVR <1.6 indicates low-risk CPAM; manage expectantly with serial ultrasounds every 4 weeks and weekly CVR monitoring.
  • CVR >1.6 carries 75% hydrops risk; refer to fetal center for betamethasone, frequent monitoring, and potential fetal intervention.
  • Macrocystic lesions with hydrops <32 weeks require thoracoamniotic shunt; microcystic lesions may need open fetal resection.
  • 50-60% of CPAMs regress prenatally; peak growth occurs at 26-28 weeks gestation before potential involution.
  • Postnatal risks include air trapping causing respiratory distress, recurrent infections, and rare malignant transformation to PPB.

Keywords

Hashtags

Full guideline text

Click "Show full text" to view the full text (3504 characters)

How to cite: GlobalCastMD. Congenital Pulmonary Airway Malformation: APSA Prenatal Counseling Series. GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/2163

Comments

Loading comments...